Oindrila Rahaman
Kolkata, WB 700091, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Dysregulation of anti-Ro60 B cell autoreactivity in systemic lupus erythematosus.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
Mitigating hERG Liability of Toll-Like Receptor 9 and 7 Antagonists through Structure-Based Design.
Journal: ChemMedChem
Published: February 08, 2023
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits.
Journal: Journal of medicinal chemistry
Published: August 12, 2022
Endocannabinoids in immune regulation and immunopathologies.
Journal: Immunology
Published: December 22, 2020
The RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response.
Journal: Nature communications
Published: October 26, 2020
Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations.
Journal: European journal of medicinal chemistry
Published: January 25, 2020
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells.
Journal: Frontiers in immunology
Published: May 01, 2019
Role of Ca2+ in toll-like receptor 9 activation in human plasmacytoid dendritic cells.
Journal: Cytokine
Published: January 01, 2019
Cutting Edge: Dysregulated Endocannabinoid-Rheostat for Plasmacytoid Dendritic Cell Activation in a Systemic Lupus Endophenotype.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 19, 2018
Activity-guided development of potent and selective toll-like receptor 9 antagonists.
Journal: European journal of medicinal chemistry
Published: July 23, 2018
Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell Activation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 07, 2017
Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism.
Journal: European journal of medicinal chemistry
Published: January 31, 2017
Last Updated: 09/26/2026